PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALPN vs. RXST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALPN and RXST is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ALPN vs. RXST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember0
-33.52%
ALPN
RXST

Key characteristics

Fundamentals

Market Cap

ALPN:

$4.46B

RXST:

$1.53B

EPS

ALPN:

-$0.64

RXST:

-$0.81

Total Revenue (TTM)

ALPN:

$37.89M

RXST:

$138.39M

Gross Profit (TTM)

ALPN:

$37.59M

RXST:

$87.81M

EBITDA (TTM)

ALPN:

-$20.85M

RXST:

-$26.47M

Returns By Period


ALPN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

RXST

YTD

-7.74%

1M

-16.70%

6M

-34.82%

1Y

-4.69%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALPN vs. RXST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alpine Immune Sciences, Inc. (ALPN) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALPN, currently valued at 4.23, compared to the broader market-4.00-2.000.002.004.23-0.09
The chart of Sortino ratio for ALPN, currently valued at 7.68, compared to the broader market-4.00-2.000.002.004.007.680.27
The chart of Omega ratio for ALPN, currently valued at 2.55, compared to the broader market0.501.001.502.002.551.03
The chart of Calmar ratio for ALPN, currently valued at 15.13, compared to the broader market0.002.004.006.0015.13-0.11
The chart of Martin ratio for ALPN, currently valued at 83.67, compared to the broader market0.0010.0020.0083.67-0.26
ALPN
RXST


Rolling 12-month Sharpe Ratio0.002.004.006.008.00JulyAugustSeptemberOctoberNovemberDecember
4.23
-0.09
ALPN
RXST

Dividends

ALPN vs. RXST - Dividend Comparison

Neither ALPN nor RXST has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ALPN vs. RXST - Drawdown Comparison


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember0
-42.14%
ALPN
RXST

Volatility

ALPN vs. RXST - Volatility Comparison

The current volatility for Alpine Immune Sciences, Inc. (ALPN) is 0.00%, while RxSight, Inc. (RXST) has a volatility of 13.80%. This indicates that ALPN experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember0
13.80%
ALPN
RXST

Financials

ALPN vs. RXST - Financials Comparison

This section allows you to compare key financial metrics between Alpine Immune Sciences, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab